Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (3634)	4/28/1998 9:17:00 PM
From: A. K. Giddings	Respond to of 7041

There was a somewhat favorable mention in a Newsweek article out just this week - I wonder if it may be contributing to the most recent run up... Excerpt from "Take a pill and call me tonight" <<<<<Moreover, Viagra won't have the market to itself forever; there are at least two other pills and a topical gel now in tests. One of the pills, Zonagen's Vasomax (produced under license by Schering-Plough), has a biochemical mechanism similar to Viagra's and could be ready for sale late this year or next. But the potential market is vast--at least a substantial fraction of the 10 million to 20 million American men who suffer some degree of impotence. This is a horde certain to be augmented by male baby boomers turning 50 at the rate of 5,000 a day over the next decade.>>>> Newsweek 5/4/98 Business/ Drugs: Take a Pill And Call Me Tonight